Pharco & Amria
Monthly Turn over 10,000,000 le from OTC line (Rany- Depovit- Ketofan- babydrink- pharcopental) from 2011 till now.
Pharco & Amria
T3A
competent franchisee for T3A portfolio beginning from backend (upstream Activities) ending by Frontend (Downstream activities) With monthly turn over 3 million /month from 2010 till now Portfolio entails: cefoperazone sulbactam 1.5 gm vial Cefotaxime Sodium1 gm – 0.5 gm ---- 2 gm Isofurn
T3A
Pharmacell (Egyptian hospital line products)
Annual turn over 1.5 million (Discontinuity due to financial incapability)
Pharmacell
Glenmark (Indian Multinational giant )
Dedicated product line for cosmotheutical products Turn over monthly 250,000 le/month from 2012
Glenmark
Healthwise (food supplement portfolio) USA origin
Undergoing proceeding registration process.
Healthwise
© Copyright 2026. Deeplook Arabia